June 8, 2021

M&A nel settore Life Sciences: uno sguardo multi-disciplinare

16 giugno 2021

Gli aspetti legali delle operazioni di M&A nel Life Sciences, soprattutto nei settori farmaceutico e dei medical devices, richiedono un approccio sistematico e multidisciplinare da calibrare sulle specificità operative, economiche e regolamentari del settore e della singola target.

Nel corso del webinar, identificheremo criticità, trend e best practice, prendendo in considerazione le peculiarità del settore e il loro possibile impatto, sotto il profilo legale, su struttura, valutazione, contenuto ed esecuzione di una operazione di M&A e sui principali meccanismi contrattuali. Facendo riferimento a casi concreti, analizzeremo tematiche M&A connesse agli aspetti regolamentari e di compliance, di appalti pubblici e antitrust fino alle recenti novità in tema di “Golden Power”.

Il seminario si rivolge ad aziende del settore, investitori, banche d’affari e società di consulenza.

Interverranno:

Ilaria Curti – Compliance
Luca Gambini – M&A, Life Sciences
Enzo Marasà – EU & Competition Law
Elisa Stefanini – Regulatory, Life Sciences

Tag: COVID-19, Mergers & Acquisitions, Medical Devices

< Back to blog

Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.

...

Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

Flash News

March 20, 2023

Today, Regulation (EU) 2023/607 extending the transitional provisions for the placing on the market and putting into service of certain medical devices and in vitro diagnostic medical device...

January 31, 2023

Clinical trials: Ministry of Health signed off on decrees that (i) reorganize ethics committees and coordinate their activities, (ii) determine the single tariff for the authorization proced...

December 19, 2022

On 13 December 2022, EMA, European Commission and HMA jointly adopted a recommendation paper on the introduction of decentralised elements in the conduct of Clinical Trials in the EU/EEA

September 21, 2022

Payback for medical devices: Decree quantifying the exceeding of the expenditure ceiling for medical devices at national and regional level for the years 2015, 2016, 2017 and 2018 published ...

September 1, 2022

The 2021 annual law for market and competition addressing, as to the healthcare sector, reimbursement of drugs, intermediate distribution, patent linkage and institutional accreditation of p...

Search by...